Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

THIOTEPA vs THYMOCYTE IMMUNE GLOBULIN NOS: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

THIOTEPA vs THYMOCYTE IMMUNE GLOBULIN NOS: Safety Overview

Metric THIOTEPA THYMOCYTE IMMUNE GLOBULIN NOS
Total FAERS Reports 6,836 5,559
Deaths Reported 1,867 1,474
Death Rate 27.3% 26.5%
Hospitalizations 1,184 2,161
Average Patient Age 25.7 yrs 35.4 yrs
% Female Patients 44.5% 49.3%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Dr.Reddy's Laboratories Inc., N/A
Route INTRACAVITARY N/A
Marketing Status Discontinued N/A